NCT01952509View on ClinicalTrials.gov

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

169

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Rheumatoid Arthritis
Trial Locations (6)

0

Cartago

San José

10208

Santo Domingo

32400

Panama City

Unknown

Guatemala City

Panama City

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01952509 - A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter